87.26
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$85.36
Offen:
$88.17
24-Stunden-Volumen:
8.93M
Relative Volume:
1.38
Marktkapitalisierung:
$70.01B
Einnahmen:
$20.38B
Nettoeinkommen (Verlust:
$2.26B
KGV:
33.29
EPS:
2.6214
Netto-Cashflow:
$3.63B
1W Leistung:
+3.08%
1M Leistung:
+2.17%
6M Leistung:
+13.25%
1J Leistung:
-3.78%
Colgate Palmolive Co Stock (CL) Company Profile
Firmenname
Colgate Palmolive Co
Sektor
Telefon
(212) 310-2000
Adresse
300 PARK AVE, NEW YORK, NY
Compare CL vs PG, UL, KVUE, KMB
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CL
Colgate Palmolive Co
|
87.26 | 70.01B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
PG
Procter Gamble Co
|
147.26 | 342.91B | 86.72B | 16.69B | 15.03B | 6.8375 |
|
UL
Unilever Plc Adr
|
59.76 | 130.51B | 56.67B | 6.96B | 7.39B | 3.1265 |
|
KVUE
Kenvue Inc
|
17.43 | 33.46B | 15.12B | 1.47B | 1.72B | 0.764 |
|
KMB
Kimberly Clark Corp
|
97.67 | 32.42B | 16.56B | 1.75B | 1.84B | 6.36 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-03-31 | Herabstufung | TD Cowen | Buy → Hold |
| 2026-03-30 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2026-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-11 | Herabstufung | Argus | Buy → Hold |
| 2025-12-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2024-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2024-09-24 | Eingeleitet | Piper Sandler | Overweight |
| 2024-09-16 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-09-09 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-23 | Eingeleitet | TD Cowen | Buy |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-03-01 | Fortgesetzt | Goldman | Buy |
| 2024-01-29 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-13 | Eingeleitet | Jefferies | Buy |
| 2023-10-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-09-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-17 | Eingeleitet | Citigroup | Buy |
| 2023-01-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-22 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-10-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-01 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-05-03 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-04-08 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-02-02 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-01-31 | Bestätigt | Citigroup | Neutral |
| 2022-01-31 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-31 | Bestätigt | Deutsche Bank | Buy |
| 2022-01-31 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-31 | Bestätigt | Wells Fargo | Underweight |
| 2021-12-16 | Eingeleitet | Redburn | Neutral |
| 2021-10-05 | Fortgesetzt | BofA Securities | Neutral |
| 2021-09-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-06-24 | Eingeleitet | UBS | Buy |
| 2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-02-01 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2021-01-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-01-26 | Hochstufung | Berenberg | Sell → Hold |
| 2021-01-20 | Eingeleitet | Bernstein | Underperform |
| 2021-01-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-07-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-03-27 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-27 | Hochstufung | SunTrust | Hold → Buy |
| 2020-03-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-03 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-02-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-12-19 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-10-16 | Eingeleitet | Berenberg | Sell |
| 2019-04-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-07 | Eingeleitet | Credit Suisse | Underperform |
| 2019-02-11 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2019-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2019-01-09 | Hochstufung | Goldman | Neutral → Buy |
| 2018-10-29 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Herabstufung | SunTrust | Buy → Hold |
| 2018-07-30 | Herabstufung | Macquarie | Outperform → Neutral |
| 2018-05-25 | Hochstufung | Argus | Hold → Buy |
| 2018-04-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Colgate Palmolive Co Aktie (CL) Neueste Nachrichten
Colgate-Palmolive Company (NYSE:CL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Colgate-Palmolive Co (CL) Q1 2026 Earnings Call Highlights: Stro - GuruFocus
Colgate-Palmolive (CL) One Off Loss Hits Margins And Tests Premium P E Narrative - simplywall.st
MSN Money - MSN
Is Colgate-Palmolive (CL) 3.9% Undervalued After Q1 2026? GAAP E - GuruFocus
Colgate-Palmolive stock price forecast: $89.50 resistance as CL jumps 3.54% - Traders Union
Buying pressure lifts Colgate-Palmolive stock higher in today's trading - Traders Union
What's Going On With Colgate-Palmolive Stock Friday?Colgate-Palmolive (NYSE:CL) - Benzinga
Colgate-Palmolive warns of $300M cost hit from Middle East conflict - CTV News
Colgate-Palmolive beats Q1 estimates on strong international demand - 93.3 The Drive
Colgate Q1 2026 slides: beats forecasts as innovation lifts share - Investing.com
Earnings call transcript: Colgate-Palmolive Q1 2026 beats forecasts, stock rises - Investing.com
Colgate Growth Beats as Global Consumers Offset US Weakness - Bloomberg.com
Colgate-Palmolive (NYSE:CL) Delivers Top-Line Beat as Full-Year Margin Outlook Dulls Q1 EPS Miss - ChartMill
Colgate-Palmolive (NYSE: CL) grows Q1 2026 sales while expanding major productivity program - Stock Titan
Colgate-Palmolive beats Q1 estimates on strong international demand By Reuters - Investing.com
Colgate-Palmolive Q1 Profit Down, Backs FY26 Earnings, Sales Growth View; Stock Up - RTTNews
Colgate-Palmolive Company $CL Stock Holdings Lowered by Savoir Faire Capital Management L.P. - MarketBeat
Colgate-Palmolive (NYSE: CL) lifts Q1 sales and expands savings program - Stock Titan
Colgate-Palmolive Sales Rise on International Growth - WSJ
Colgate-Palmolive tops Q1 expectations after broad-based growth, shares gain - Investing.com
Colgate-Palmolive: Q1 Earnings Snapshot - Barchart.com
Colgate holds 41.1% toothpaste share as quarterly sales climb 8.4% - Stock Titan
Colgate-Palmolive's Q1 net sales above forecast at $5.3B - Breakingthenews.net
State of New Jersey Common Pension Fund D Has $20.19 Million Stake in Colgate-Palmolive Company $CL - MarketBeat
Danica Pension Livsforsikringsaktieselskab Decreases Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
If you purchased Tom's toothpaste within the last 6 years, you could be eligible for a payout - MSN
Colgate earnings on deck as analysts eye North America turnaround By Investing.com - Investing.com Nigeria
Colgate earnings on deck as analysts eye North America turnaround - Investing.com
If you bought this popular toothpaste, you may be owed money from Colgate-Palmolive. Here's how to claim it - MSN
Colgate-Palmolive India Publishes Regulatory Notice for Saksham Niveshak Campaign - scanx.trade
[SCHEDULE 13G] COLGATE PALMOLIVE CO Passive Investment Disclosure (>5%) - Stock Titan
A Look At Colgate-Palmolive (CL) Valuation As Hill’s Pet Nutrition Fuels Expected 2026 Earnings Growth - simplywall.st
Wealthfront Advisers LLC Increases Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
If you bought this toothpaste, you may qualify for cash payout - MSN
Is CL Overvalued? DCF Says Worth $43 - GuruFocus
Colgate-Palmolive: A Mixed Bag in Consumer Goods Investing - The Motley Fool
Colgate-Palmolive Co (CL) Stock Price, Trades & News - GuruFocus
Colgate-Palmolive Company $CL Shares Purchased by Concurrent Investment Advisors LLC - MarketBeat
Advisors Capital Management LLC Sells 205,500 Shares of Colgate-Palmolive Company $CL - MarketBeat
Volkswagen, Colgate, Apple: The return of the ‘agency within an agency’ - Storyboard18
Colgate-Palmolive Announces Webcast of its 2026 First Quarter Earnings Conference Call May 1, 2026Now at 8:00 a.m. ET and its 2026 Annual Meeting of Stockholders on May 8, 2026 at 10:00 a.m. ET - ChartMill
Colgate-Palmolive syndicates product data across sellers - Digital Commerce 360
Rothschild & Co upgrades Colgate-Palmolive (CL) - MSN
Colgate's Q1 Earnings Upcoming: Here's What Investors Should Know - Yahoo Finance
Inscription Capital LLC Has $3.82 Million Stake in Colgate-Palmolive Company $CL - MarketBeat
Vanguard Group Inc. Increases Position in Colgate-Palmolive Company $CL - MarketBeat
The Oral Edge - IMPACT Magazine
Coca-Cola, Colgate-Palmolive, and PepsiCo: Dividend Growth Stocks for 2026News and Statistics - IndexBox
How Colgate-Palmolive’s (CL) DEI and Board Structure Stance Has Shifted Its Governance Investment Story - simplywall.st
Finanzdaten der Colgate Palmolive Co-Aktie (CL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Colgate Palmolive Co-Aktie (CL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tsourapas Panagiotis | COO, Eur., APac, Afr Eur, Skin |
Feb 12 '26 |
Option Exercise |
76.41 |
15,000 |
1,146,150 |
25,415 |
| Tsourapas Panagiotis | COO, Eur., APac, Afr Eur, Skin |
Feb 11 '26 |
Sale |
94.61 |
35,000 |
3,311,326 |
10,415 |
| Tsourapas Panagiotis | COO, Eur., APac, Afr Eur, Skin |
Feb 12 '26 |
Sale |
97.81 |
15,000 |
1,467,111 |
10,415 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):